Furthermore, expression of CD320 is reported to be highest in actively proliferating cells and is strongly upregulated in many cancer cells, prompting interest in its potential targeting through receptor directed drug delivery23, 24 or its exploitation for tumour diagnostics. This evidence concerns the gene CD320 and neoplasm.